Literature DB >> 18566576

Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines.

N V Valkovskaya1.   

Abstract

BACKGROUND: One of the most characteristic features of malignant tissue is the high level of intratumoral hypoxia, which is considered as a powerful factor for induction of tumor aggressiveness and malignant progression. Pancreatic cancer (PC) is a near fatal disease with very unfavorable clinical outcome despite the application of different treatment regimes. It was shown that PC is characterized by high level of hypoxia. AIM: To clarify the correlation between tumor hypoxia and ADAM8 protein expression.
MATERIALS AND METHODS: ASPC-1, Panc-1, BxPC-3, Capan-1, MiaPaCa-2, Colo-357, Su8686 and T3M4 cell lines were used in the study. Expression of mRNA ADAM8 was evaluated by real-time quantitative polymerase chain reaction method. Immunoblot analysis was used to evaluate the expression of ADAM8 protein.
RESULTS: Hypoxia induced a 2.5-5.9-fold increase of ADAM8 mRNA levels of in the examined pancreatic cancer cell lines except Panc-1 (p=0.046). On the protein level, hypoxia induced a 1.2-5.9-fold increase of the ADAM8 prodomain removal form (90 kDa) in 5/8 pancreatic cancer cells. Moreover, hypoxia induced a 1.3-2.0-fold increase of the remnant form ADAM8 (60 kDa) in 4/8 pancreatic cancer cell lines: Aspc-1, Colo-357, Panc-1, T3M4.
CONCLUSION: It was observed the clear tendency in the increase both of ADAM8 mRNA and ADAM8 protein levels in pancreatic cancer cell lines under hypoxia compared to normal conditions of oxygenation. A potential role of ADAM8 as a hypoxia-dependent protein in the pathogenesis and evolution of pancreatic cancer that is characterized by high level of intratumoral hypoxia can be suggested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566576

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  6 in total

1.  Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.

Authors:  Shiming He; Lianshu Ding; Yizhan Cao; Gang Li; Jianping Deng; Yanyang Tu; Boliang Wang
Journal:  Med Oncol       Date:  2011-10-09       Impact factor: 3.064

2.  Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.

Authors:  Zhehai Li; Qiande Liao; Yuchi Wu; Mingmei Liao; Yuqin Hao; Shengbin Zhang; Shipeng Song; Bing Li; Yang-de Zhang
Journal:  Pathol Oncol Res       Date:  2012-01-05       Impact factor: 3.201

3.  High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yun Zhang; Yong-Fei Tan; Chao Jiang; Kai Zhang; Tian-Zhou Zha; Miao Zhang
Journal:  Pathol Oncol Res       Date:  2012-09-12       Impact factor: 3.201

4.  ADAM8 as a drug target in pancreatic cancer.

Authors:  Uwe Schlomann; Garrit Koller; Catharina Conrad; Taheera Ferdous; Panagiota Golfi; Adolfo Molejon Garcia; Sabrina Höfling; Maddy Parsons; Patricia Costa; Robin Soper; Maud Bossard; Thorsten Hagemann; Rozita Roshani; Norbert Sewald; Randal R Ketchem; Marcia L Moss; Fred H Rasmussen; Miles A Miller; Douglas A Lauffenburger; David A Tuveson; Christopher Nimsky; Jörg W Bartsch
Journal:  Nat Commun       Date:  2015-01-28       Impact factor: 14.919

5.  Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer.

Authors:  Zuli Yang; Yang Bai; Lijun Huo; Hao Chen; Jintuan Huang; Jizheng Li; Xinjuan Fan; Zihuan Yang; Lei Wang; Jianping Wang
Journal:  BMC Cancer       Date:  2014-08-07       Impact factor: 4.430

6.  Evidence for Adaptation to the Tibetan Plateau Inferred from Tibetan Loach Transcriptomes.

Authors:  Ying Wang; Liandong Yang; Kun Zhou; Yanping Zhang; Zhaobin Song; Shunping He
Journal:  Genome Biol Evol       Date:  2015-10-09       Impact factor: 3.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.